SP
Shah Pritesh Directeur Commercial
OFFICER M
US US · SEC (Form 4)
Explore the complete record of transactions filed by Shah Pritesh, Directeur Commercial. Director active across 1 companies, notably NovoCure Ltd. Aggregated, 17 filings have been recorded. Total volume traded: €9.8m. The latest transaction was disclosed on 31 July 2021 — Levée d'options. Regulator: SEC (Form 4). All data is openly available.
Declarations 17 total
€481,338 3,717 shares @ €129.4964 0.033% mcap 4.3% of flow
Ordinary Shares
SEC:0001645113-22-000031:0 · 31 Jul 2021
€338,587 5,294 shares @ €63.9568 0.023% mcap 3.0% of flow
Ordinary Shares
SEC:0001645113-22-000030:0 · 7 Mar 2022
021,714 shares 0
Ordinary Shares
SEC:0001645113-22-000020:0 · 3 Mar 2022
€18,157 156 shares @ €116.3913 0.0012% mcap 0.4% of flow
Ordinary Shares
SEC:0001645113-21-000106 · 2 Sept 2021
€18,157 156 shares @ €116.3913 0.0012% mcap 0.2% of flow
Ordinary Shares
SEC:0001645113-21-000106:0 · 2 Sept 2021
€259,169 2,063 shares @ €125.6272 0.018% mcap 5.1% of flow
Ordinary Shares
SEC:0001645113-21-000100 · 4 Aug 2021
€259,169 2,063 shares @ €125.6272 0.018% mcap 2.3% of flow
Ordinary Shares
SEC:0001645113-21-000100:0 · 4 Aug 2021
€208,230 1,654 shares @ €125.8948 0.014% mcap 4.1% of flow
Ordinary Shares
SEC:0001645113-21-000097 · 3 Aug 2021
€208,230 1,654 shares @ €125.8948 0.014% mcap 1.9% of flow
Ordinary Shares
SEC:0001645113-21-000097:0 · 3 Aug 2021
€17,858 154 shares @ €115.9641 0.0012% mcap 0.4% of flow
Restricted Share Units
SEC:0001645113-21-000083 · 6 Jul 2021
€17,858 154 shares @ €115.9641 0.0012% mcap 0.2% of flow
Restricted Share Units
SEC:0001645113-21-000083:0 · 6 Jul 2021
€4m 23,540 shares @ €176.6268 0.29% mcap 37.3% of flow
Ordinary Shares
SEC:0001645113-21-000080:0 · 10 Jun 2021
€4m 23,540 shares @ €176.6268 0.29% mcap 82.2% of flow
Ordinary Shares
SEC:0001645113-21-000080 · 10 Jun 2021
1,290 shares
Ordinary Shares
SEC:0001645113-21-000065 · 5 May 2021
€214,503 1,290 shares @ €166.2812 0.015% mcap 1.9% of flow
Ordinary Shares
SEC:0001645113-21-000065:0 · 5 May 2021
€394,789 2,333 shares @ €169.2193 0.027% mcap 7.8% of flow
Ordinary Shares
SEC:0001645113-21-000063 · 3 May 2021
€394,789 2,333 shares @ €169.2193 0.027% mcap 3.5% of flow
Ordinary Shares
SEC:0001645113-21-000063:0 · 3 May 2021
About Shah Pritesh Shah Pritesh is the Chief Commercial Officer of NovoCure Ltd. He is responsible for the company's sales and marketing strategies.